Published in Hepatitis Weekly, November 5th, 2001
"Granulocyte-macrophage colony stimulating factor (GM-CSF) has immunoregulatory and antiviral effects, and may thus be promising for the treatment of chronic hepatitis B," Hui-Lin Wu and colleagues, National Taiwan University, explained.
GM-CSF is species specific and can be isolated in woodchucks, animals that can contract woodchuck hepatitis virus (WHV) infection, which resembles HBV infection in humans. Researchers at National Taiwan...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.